NCT04952116 is a NA clinical trial of Eyelid reconstruction in Eyelid Defects, sponsored by Sohag University.

Who is sponsoring NCT04952116?

NCT04952116 is sponsored by Sohag University.

What drugs are being tested in NCT04952116?

Interventions in NCT04952116: Eyelid reconstruction.

What condition does NCT04952116 study?

NCT04952116 studies Eyelid Defects, Periocular Tumors.

Is NCT04952116 still recruiting?

NCT04952116 is currently status unknown. Last updated 7 July 2021.

Last reviewed 2021-07-07 · How we verify

NCT04952116

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aesthetic and Functional Outcomes of Eyelid Reconstruction After Excision of Periocular Tumors

Status unknown NA Last updated 7 July 2021

What this trial tests

NA trial testing Eyelid reconstruction in Eyelid Defects in 20 participants. Status unknown.

Timeline

1 August 2021

Primary endpoint
1 June 2022

1 August 2022

Quick facts

Lead sponsor	Sohag University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 August 2021
Primary completion	1 June 2022
Estimated completion	1 August 2022
Sites	1 location across Egypt

Drugs / interventions tested

Eyelid reconstruction

Conditions studied

Eyelid Defects — all drugs for Eyelid Defects →
Periocular Tumors — all drugs for Periocular Tumors →

Sponsor

Sohag University

Who can join

Eligibility, any sex, with Eyelid Defects or Periocular Tumors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

* To determine the aesthetic and functional outcomes of different techniques used in eyelid reconstruction following periocular defects. * To determine the complications of eyelid reconstruction and how to prevent them

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04952116 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sohag University
Last refreshed: 7 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04952116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing